paroxetine has been researched along with Amentia in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boudreau, DM; Crane, PK; Edwards, KL; Fullerton, SM; Gray, SL; Heath, L; Larson, EB; Thummel, K | 1 |
| Belcher, DC; Dowben, JS; Keltner, NL; Kowalski, PC | 1 |
| Aparasu, RR; Bali, V; Carnahan, RM; Chatterjee, S; Chen, H; Johnson, ML | 1 |
| Antonello, RM; Bava, A; Cazzato, G; Moretti, R; Torre, P | 1 |
| Lebert, F | 1 |
| Deakin, JB; Hodges, JR; Nestor, PJ; Rahman, S; Sahakian, BJ | 1 |
| Hausner, RS | 1 |
| Al Chekakie, MO; Ketz, JM; Whinney, CM | 1 |
| Darby, AL; Lesser, IM; Miller, BL; Swartz, JR | 1 |
| Burke, WJ; Dewan, V; Folks, DG; Nadolny, GC; Roccaforte, WH; Wengel, SP | 1 |
| Shin, KJ; Stewart, JT | 1 |
| Bray, J; Hunter, BN; Katona, CL | 1 |
| Shepherd, J; Strachan, J | 1 |
| Draper, B; Meares, S | 1 |
| Bassanelli, AG; Naughton, BJ; Ramadan, FH | 1 |
| Becker, JT; Butters, MA; Mulsant, BH; Nebes, RD; Pollock, BG; Reynolds, CF; Zmuda, MD | 1 |
| Leard-Hansson, J | 1 |
2 review(s) available for paroxetine and Amentia
| Article | Year |
|---|---|
Biological Perspectives: Huntington's Disease.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain; Cognition Disorders; Dementia; Humans; Huntington Disease; Magnetic Resonance Imaging; Male; Memory, Short-Term; Mood Disorders; Olanzapine; Paroxetine | 2015 |
[Serotonin reuptake inhibitors in depression of Alzheimer's disease and other dementias].
Topics: Aged; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Dementia; Depression; Fluoxetine; Humans; Neuropsychological Tests; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Time Factors; Trazodone | 2003 |
6 trial(s) available for paroxetine and Amentia
| Article | Year |
|---|---|
Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study.
Topics: Aged; Caregivers; Cost of Illness; Dementia; Female; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Paroxetine; Piracetam; Selective Serotonin Reuptake Inhibitors; Social Behavior Disorders | 2003 |
Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial.
Topics: Aged; Association Learning; Attention; Cognition; Dementia; Double-Blind Method; Female; Frontal Lobe; Humans; Male; Memory; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Reaction Time; Risk-Taking; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Time Factors; Visual Perception | 2004 |
Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Compulsive Behavior; Dementia; Depressive Disorder; Female; Fluoxetine; Frontal Lobe; Humans; Impulsive Behavior; Male; Middle Aged; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Temporal Lobe; Treatment Outcome | 1997 |
A double-blind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia.
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Dementia; Depressive Disorder; Double-Blind Method; Drug Tolerance; Female; Humans; Imipramine; Male; Paroxetine; Prospective Studies; Time Factors; Treatment Outcome | 1998 |
Treatment of verbal agitation with a selective serotonin reuptake inhibitor.
Topics: Aged; Aged, 80 and over; Dementia; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Verbal Behavior | 2000 |
Changes in cognitive functioning following treatment of late-life depression.
Topics: Aged; Antidepressive Agents; Cognition Disorders; Comorbidity; Dementia; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Treatment Outcome | 2000 |
9 other study(ies) available for paroxetine and Amentia
| Article | Year |
|---|---|
Cumulative Antidepressant Use and Risk of Dementia in a Prospective Cohort Study.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cholinergic Antagonists; Dementia; Depression; Female; Humans; Independent Living; Male; Paroxetine; Proportional Hazards Models; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors; Washington | 2018 |
Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors.
Topics: Aged; Aged, 80 and over; Causality; Cohort Studies; Comorbidity; Dementia; Depressive Disorder; Female; Homes for the Aged; Humans; Male; Nursing Homes; Paroxetine; Proportional Hazards Models; Retrospective Studies; Risk; Selective Serotonin Reuptake Inhibitors; United States | 2015 |
Early Alzheimer's disease.
Topics: Dementia; Depression; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2004 |
Hypothermia in a patient receiving risperidone and paroxetine.
Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dementia; Female; Humans; Hypothermia; Paroxetine; Risperidone | 2006 |
The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychotic Disorders; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Paroxetine treatment of sexual disinhibition in dementia.
Topics: Age Factors; Aged; Comorbidity; Dementia; Humans; Male; Paraphilic Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1997 |
Hyponatraemia associated with the use of selective serotonin re-uptake inhibitors.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Dementia; Depressive Disorder; Drug Monitoring; Female; Fluoxetine; Humans; Hyponatremia; Male; Middle Aged; Paroxetine; Patient Admission; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sodium | 1998 |
Treatment of vocally disruptive behaviour of multifactorial aetiology.
Topics: Aged; Akathisia, Drug-Induced; Behavior Therapy; Dementia; Depression; Female; Homes for the Aged; Humans; Mental Disorders; Noise; Nursing Homes; Paroxetine; Patient Compliance; Physical Therapy Modalities; Psychomotor Agitation; Restraint, Physical; Risperidone; Verbal Behavior | 1999 |
Treatment of mild depression in elderly patients.
Topics: Aged; Antidepressive Agents, Second-Generation; Dementia; Depression; Dysthymic Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2000 |